Cathie Wood’s ARK Invest Buys Over 7 Million Shares of This Biotech-Focused SPAC

On August 9, a couple of Cathie Wood's ARK Invest funds bought over 7 million shares of Soaring Eagle Acquisition, a biotech-focused special purpose acquisition company.

Published August 10, 2021, 8:40am ET · 1 min read

This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.

© pictures-of-money / Flickr

A couple ARK Invest exchange-traded funds run by ETF star Cathie Wood bought over 7 million shares of Soaring Eagle Acquisition Corp. (NASDAQ: SRNG) on Monday, as the share price of these exchange-traded funds were up around 1% in the day’s session. Their share prices have greatly improved over the past year.

Specifically, ARK Genomic Revolution ETF (NYSEARCA: ARKG) bought 4,512,926 shares of the special purpose acquisition company (SPAC), and ARK Innovation ETF (NYSEARCA: ARKK) bought 2,506,461 shares. At Monday’s closing prices, this would have valued this purchase at roughly $70.2 million. This is only a small fraction of the total holdings. ARKG is up 57% over the past 52 weeks and ARKK is up 54%.

Here is a quick look at all the purchases made by ARK ETFs:

Fund Ticker Company Shares
ARKG ADPT Adaptive Biotechnologies 232,610
ARKG SRNG Soaring Eagle Acquisition 4,512,926
ARKG SGFY Signify Health 30,490
ARKK Z Zillow 101,994
ARKK TSP TuSimple 316,814
ARKK SRNG Soaring Eagle Acquisition 2,506,461
ARKQ MKFG Markforged 57,406
ARKQ PATH UiPath 8,178
ARKW LPSN LivePerson 22,696
ARKW Z Zillow 24,750
ARKW PATH UiPath 8,641
ARKX BLDE Blade Air Mobility 16,370
ARKX KTOS Kratos Defense & Security Solutions 49,634

[nativounit]
Catherine Wood, the CEO and CIO of ARK Investment Management, is a minority and nonvoting shareholder of 24/7 Wall St.
[recirclink id=931736][wallst_email_signup]

Contact [email protected] for any questions or corrections.

Chris Lange

Chris Lange is a financial and geopolitical writer with more than a decade of experience covering a myriad of topics. He has published thousands of articles for 24/7 Wall St., with past coverage focused heavily on stocks, IPOs, healthcare, defense, global affairs, and technology.

His work has been quoted, or referenced by a number of outlets including Business Insider, USA Today, Yahoo Finance, MSN, The Motley Fool, and many other publications. A graduate of Southwestern University, he studied business with a focus on investments and has previous experience in banking and startups.

When not reading or writing the news, he is following his passion for Lacrosse, playing chess, or building solar projects with his dad.

All articles →